药物发现中的人工智能市场：按产品、应用和最终用户划分-俄罗斯-乌克兰衝突和高通胀-2023-2030年全球预测

预计到 2023 年，药物发现领域人工智能的全球市场将增长到 10.8558 亿美元，复合年增长率为 26.80%，到 2030 年将达到 581772 万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估药物发现市场中的全球人工智能至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对总收入、客户群和其他关键指标的贡献，可以让公司更好地了解他们的表现以及他们在争夺市场份额时面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细资讯。

4.市场趋势：全面了解俄罗斯-乌克兰衝突和高通胀。

5.竞争评估和资讯：对主要公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1. 人工智能在药物发现领域的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 对塑造全球人工智能药物发现市场的抑制因素和影响是什么？

3.预测期内，全球人工智能药物发现市场应投资哪些产品/细分市场/应用/领域？

4.全球人工智能药物发现市场的竞争策略是什么？

5.全球人工智能药物发现市场的技术趋势和监管框架是什么？

6.全球人工智能药物发现市场主要供应商的市场份额是多少？

7.什么形式和战略举措适合进入人工智能药物发现的全球市场？

目录

第 1 章前言

第 2 章研究方法

第 3 章执行摘要

第 4 章市场概述

第 5 章市场洞察

• 市场动态
  • 促进因素
    • 药物发现过程管理和降低成本的要求
    • 管理临床前研究期间生成的大量数据的需求日益增加
    • 生物製药公司的采用率有所提高
  • 抑制因素
    • 缺乏熟练的专业人员
  • 机会
    • 利用 AI Cloud 构建简化且自动化的药物发现方法
    • 增加研发投入
  • 作业
    • 数据集使用限制
• 市场趋势
• 新冠肺炎 (COVID-19) 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积影响
• 波特五力分析
• 价值炼和关键路径分析
• 监管框架
• 客户定制

第 6 章药物发现中的人工智能市场：通过提供

• 服务
• 软件

第 7 章药物发现中的人工智能市场：按应用划分

• 循环系统疾病
• 肿瘤免疫学
• 代谢性疾病
• 神经退行性疾病

第 8 章药物发现中的人工智能市场：按最终用户划分

• 委託研究组织
• 製药和生物技术公司
• 研究中心以及学术和政府机构

第 9 章美洲药物发现中的人工智能市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第 10 章亚太地区药物发现中的人工智能市场

• 澳大利亚
• 中国
• 印度
• 印度尼西亚
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第 11 章欧洲、中东和非洲药物发现中的人工智能市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第 12 章竞争态势

• FPNV定位矩阵
• 市场份额分析：按主要公司划分
• 竞争情景分析：主要公司

第 13 章上市公司名单

第 14 章附录

• 讨论指南
• 关于许可证和价格

The Global Artificial Intelligence in Drug Discovery Market is forecasted to grow significantly, with a projected USD 1,085.58 million in 2023 at a CAGR of 26.80% and expected to reach a staggering USD 5,817.72 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Artificial Intelligence in Drug Discovery Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Artificial Intelligence in Drug Discovery Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offering, market is studied across Services and Software. The Services commanded largest market share of 55.21% in 2022, followed by Software.

Based on Application, market is studied across Cardiovascular Disease, Immuno-Oncology, Metabolic Diseases, and Neurodegenerative Diseases. The Immuno-Oncology commanded largest market share of 28.63% in 2022, followed by Cardiovascular Disease.

Based on End User, market is studied across Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Centers and Academic & Government Institutes. The Pharmaceutical & Biotechnology Companies commanded largest market share of 58.18% in 2022, followed by Contract Research Organizations.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.44% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Artificial Intelligence in Drug Discovery Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Artificial Intelligence in Drug Discovery Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Drug Discovery Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Drug Discovery Market?

4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Drug Discovery Market?

5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Drug Discovery Market?

6. What is the market share of the leading vendors in the Global Artificial Intelligence in Drug Discovery Market?

7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence in Drug Discovery Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Artificial Intelligence in Drug Discovery Market, by Offering, 2022 vs 2030
• 4.3. Artificial Intelligence in Drug Discovery Market, by Application, 2022 vs 2030
• 4.4. Artificial Intelligence in Drug Discovery Market, by End User, 2022 vs 2030
• 4.5. Artificial Intelligence in Drug Discovery Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand to Control Drug Discovery Process and Reduce Cost
    • 5.1.1.2. Increasing Need to Manage the Large Data Generated During Preclinical Studies
    • 5.1.1.3. Increasing Adoption across Biopharmaceutical Companies
  • 5.1.2. Restraints
    • 5.1.2.1. Unavailability of Skilled Professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
    • 5.1.3.2. Increasingly Growing R&D Investments
  • 5.1.4. Challenges
    • 5.1.4.1. Limited Availability of Data Sets
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Artificial Intelligence in Drug Discovery Market, by Offering

• 6.1. Introduction
• 6.2. Services
• 6.3. Software

7. Artificial Intelligence in Drug Discovery Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Disease
• 7.3. Immuno-Oncology
• 7.4. Metabolic Diseases
• 7.5. Neurodegenerative Diseases

8. Artificial Intelligence in Drug Discovery Market, by End User

• 8.1. Introduction
• 8.2. Contract Research Organizations
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Research Centers and Academic & Government Institutes

9. Americas Artificial Intelligence in Drug Discovery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Artificial Intelligence in Drug Discovery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Intelligence in Drug Discovery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

1. Aria Pharmaceuticals

2. Atomwise, Inc.

3. BenevolentAI Limited

4. BioSymetrics Inc.

5. Cloud Pharmaceuticals, Inc.

6. Cyclica Inc.

7. Deep Genomics Incorporated

8. Envisagenics, Inc.

9. Exscientia

10. Insitro, Inc.

11. International Business Machines Corporation

12. Microsoft Corporation

13. Novartis AG

14. NVIDIA Corporation

15. Owkin, Inc.

16. Verge Genomics Inc.

17. XtalPi Inc.

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2022 VS 2030
• FIGURE 3. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2022 VS 2030 (%)
• FIGURE 5. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET DYNAMICS
• FIGURE 9. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 5. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 8. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 44. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 47. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 99. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 111. POLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. QATAR ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET LICENSE & PRICING